15 Best High-Yield Dividend Stocks for 2025 and Beyond

6. Bristol-Myers Squibb Company (NYSE:BMY)

Dividend Yield as of May 9: 5.34%

Bristol-Myers Squibb Company (NYSE:BMY) ranks sixth on our list of the best dividend stocks with high yields. The New York-based multinational pharmaceutical company specializes in developing and delivering innovative medicines. The company has pursued an aggressive acquisition strategy to diversify its pipeline beyond its established blockbuster drugs. Its recent purchases—including cancer-focused firms Mirati and RayzeBio, and neurology company Karuna—have expanded its presence in fast-growing therapeutic segments, creating new avenues for future growth.

In Q1 2025, Bristol-Myers Squibb Company (NYSE:BMY) reported revenue of $11.2 billion, reflecting a 5.6% decline from the previous year, but still surpassing analyst expectations by more than $494 million. The company’s Growth Portfolio brought in $5.6 billion, up 16% on a reported basis and 18% excluding currency impacts, with strong contributions from Opdivo, Breyanzi, Reblozyl, Camzyos, and a promising early launch of Cobenfy in the U.S.

Bristol-Myers Squibb Company (NYSE:BMY) also maintained a healthy cash position, ending the quarter with over $10.8 billion in cash and equivalents, up from $10.3 billion at the end of December. The company pays a quarterly dividend of $0.62 per share, following a 3.3% increase in December 2024, which marked its 16th consecutive annual hike. BMY has also upheld a 93-year record of uninterrupted dividend payments. As of May 9, the stock has a dividend yield of 5.34%.